Efalizumab
From IDWiki
- CD 11a inhibitor
- Monoclonal IgG1 antibody against the α subunit (CD 11a) of LFA-1
- Affects T cell activation, transfer from circulation to sites of inflammation in the skin, and T cell reactivation in the skin
- Indications include psoriasis
- Infectious complications include upper respiratory tract infections, gastroenteritis, and HSV
